The Aflac Cancer and Blood Disorders Center of Emory University is one of the leading pediatric cancer, hematology, and blood and marrow transplant (BMT) programs in the US. As such it provides advanced diagnostic and clinical care, as well as innovative treatment and research options to children, adolescents and young adults.
Dr. Richard Moriggl gave a presentation at the Aflac Leukemia/Lymphoma group meeting entitled:
"Gene dosage of STAT5 alters lymphocyte development and cancer progression with a key role for the CD8 T cell lineage"
Talks at the OeGHO annual meeting 2013 (Österreichische Gesellschaft für Hematologie und Onkologie):
“STAT5 as a novel target in myeloid neoplasms”
Richard Moriggl, Vienna, Austria
"The role of JUN proteins for NPM-ALK lymphomagenesis"
Lukas Kenner, Vienna, Austria